Comprehensive solutions for your Treg mouse and human research

Regulatory T cells (Tregs) are an important T cell subpopulation that maintains immunological homeostasis. Today, Treg-based therapy shows an enormous potential for treatment of autoimmune and autoinflammatory disorders, acute and chronic infection, allergy, metabolic inflammation, transplantation, and cancer. Therefore, it is crucial to provide reliable and trustworthy research materials alongside an easily translatable workflow into the clinic. This webinar explores Miltenyi Biotec’s innovative tools to support Treg research at every step.

 

Learning Objectives